{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:37:52Z","timestamp":1764715072199,"version":"build-2065373602"},"reference-count":29,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T00:00:00Z","timestamp":1650758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Objective: to describe the prevalences, characteristics, and survivals of patients with anti-topoisomerase 1 antibodies (ATA) and limited cutaneous systemic sclerosis (lSSc) and anti-centromere antibodies (ACA) and diffuse cutaneous systemic sclerosis (dSSc). Methods: patients with ATA lSSc or with ACA dSSc were included in a case-control retrospective study. Results: In our cohort of scleroderma, the prevalence of ACA dSSc and ATA lSSc was 1.1% (12\/1040) and 8.9% (93\/1040), respectively. ACA dSSc patients had less interstitial lung disease (ILD) (5 (41.7) vs. 74 (79.6); p &lt; 0.01), more cardiac involvement, and more muscle involvement (3 (25) vs. 4 (4.3); p = 0.03 and 4 (33.3) vs. 4 (7.5); p = 0.02,) than ATA dSSc patients. ATA lSSc patients had a higher modified Rodnan skin score than ACA lSSc patients (4 [2\u20137.5] vs. 2 [0\u20135]; p &lt; 0.01) and less cardiac or muscle involvement than ATA dSSc patients (6 (6.5) vs. 19 (20.4%); p &lt; 0.01 and 15 (16.1) vs. 54 (58.1); p &lt; 0.0001, respectively). The cumulative 5-year survival rate was 71% in ACA dSSc patients, 95% in ATA lSSc patients, 84% in ACA lSSc patients, and 66% in ATA dSSc patients (p &lt; 0.0001). Conclusion: ATA lSSc and ACA dSSc have specific characteristics when compared to ATA dSSc or ACA lSSc. ATA lSSc patients have more ILD than ACA lSSc patients, and ATA dSSc patients have the worst prognosis. Overall, inverted phenotypes show the value of a patient assessment combining antibody and skin subset and should be considered as a separate group.<\/jats:p>","DOI":"10.3390\/diagnostics12051067","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T22:22:41Z","timestamp":1650838961000},"page":"1067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes"],"prefix":"10.3390","volume":"12","author":[{"given":"Ashley","family":"Tieu","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Chaigne","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Dunogu\u00e9","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Dion","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8136-2454","authenticated-orcid":false,"given":"Alexis","family":"R\u00e9gent","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Casadevall","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Cohen","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Legendre","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence Maladies Autoimmunes Syst\u00e9miques Rares d\u2019Ile de France, H\u00f4pital Cochin, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), F-75014 Paris, France"},{"name":"APHP-CUP, H\u00f4pital Cochin, Universit\u00e9 de Paris, F-75014 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"Leroy","year":"1988","journal-title":"J. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/acr.23597","article-title":"Ultrasonography for the Assessment of Skin in Systemic Sclerosis: A Systematic Review","volume":"71","author":"Santiago","year":"2019","journal-title":"Arthritis Care Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00296-020-04761-8","article-title":"High-resolution ultrasound imaging of skin involvement in systemic sclerosis: A systematic review","volume":"41","author":"Sobolewski","year":"2021","journal-title":"Rheumatol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mvr.2017.08.004","article-title":"Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients","volume":"115","author":"Ruaro","year":"2018","journal-title":"Microvasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","article-title":"Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis","volume":"31","author":"Steen","year":"1988","journal-title":"Arthritis Rheum."},{"key":"ref_7","first-page":"2737","article-title":"Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: A report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","article-title":"Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being","volume":"29","author":"Medsger","year":"2003","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00296-013-2844-7","article-title":"The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud\u2019s phenomenon","volume":"33","author":"Damjanov","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology"},{"key":"ref_14","first-page":"1528","article-title":"Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA","volume":"34","author":"Santiago","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/rheumatology\/kew298","article-title":"Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: Determined by skin subtype or auto-antibody subtype? A long-term follow-up study","volume":"55","author":"Kranenburg","year":"2016","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semarthrit.2015.04.009","article-title":"Thinking outside the box\u2014The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect","volume":"45","author":"Srivastava","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.22747","article-title":"Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti\u2013topoisomerase I antibody","volume":"56","author":"Perera","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: Correlation with characteristic clinical features","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-019-1867-1","article-title":"Survival and prognosis factors in systemic sclerosis: Data of a French multicenter cohort, systematic review, and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"rky002","DOI":"10.1093\/rap\/rky002","article-title":"Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis","volume":"2","author":"Caetano","year":"2018","journal-title":"Rheumatol. Adv. Pract."},{"key":"ref_23","first-page":"98","article-title":"Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis","volume":"8","author":"Arandia","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor \u03b2 and Activate Fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-016-0993-2","article-title":"Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma","volume":"18","author":"Fava","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/annrheumdis-2012-202849","article-title":"The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis","volume":"73","author":"Cottrell","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically Distinct Subsets within ANCA-Associated Vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/5\/1067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:59:57Z","timestamp":1760137197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/5\/1067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,24]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["diagnostics12051067"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12051067","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2022,4,24]]}}}